CC260 is a selective PI5P4Kα and PI5P4Kβ inhibitor with K i s of 40 nM and 30 nM, respectively. CC260 does not inhibit or weakly inhibits other protein kinases, such as Plk1 and RSK2 . CC260 can be used for cell energy metabolism, diabetes and cancer research.